LF

RNDr. Monika Kvaková, PhD.   SK

Email:
monika.kvakova@upjs.sk
Homepage:
https://www.upjs.sk/LF/zamestnanec/monika.kvakova
Faculty:
LF UPJŠ - Pavol Jozef Šafárik University in Košice Faculty of Medicine
Department:
CKPV - Center of Clinical and Preclinical Research MEDIPARK
Office:
MB6O18
Phone:
+421 55 234 3265
ORCID ID:
0000-0002-9659-5584

Higher education and further qualification growth
First degree of higher education:
Faculty of Natural Sciences, Comenius University in Bratislava, 2011, Biology
Second degree of higher education:
Faculty of Natural Sciences, Comenius University in Bratislava, 2013, Biotechnology
Third degree of higher education:
Faculty of Science, PJŠU in Kosice, 2021, Biochemistry

Research /art/ teacher profile

Display details  
Selected publications

ADC- Monika Kvakova, Katarina Stroffekova, Jana Stofilova, Vladimir Girman, Alojz Bomba, Marian Antalik. Toxicological evaluation of fluorescent 11-mercaptoundecanoic gold nanoclusters as promising label-free bioimaging probes in different cancer cell lines. Toxicology in Vitro. 2021, 73, 105140, ISSN 0887-2333, https://doi.org/10.1016/j.tiv.2021.105140; 2-year IF(2020): 3.5; SJR(2019): Q2; JCR(2019): Q2

ADC- Monika Kvakova, Izabela Bertkova, Jana Stofilova, Tor C. Savidge. Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation. Foods. 2021, 10(6), 1297, https://doi.org/10.3390/foods10061297; 5-Year IF(2020): 4.957; SJR(2020): Q1; JCR(2020): Q2

ADC- Ladislav Janovec, Eva Kováčová, Martina Šemeláková, Monika Kvaková, Daniel Kupka, Dávid Jáger, Mária Kožurková. Synthesis of Novel Biologically Active Proflavine Ureas Designed on the Basis of Predicted Entropy Changes. Molecules. 2021. 26(16) art.no. 4860, s. [1-16]. ISSN 1420-3049, https://www.mdpi.com/1420-3049/26/16/4860; 5-Year IF(2020): 4.588 ;SJR(2020): Q1; JCR(2020): Q2

ADC- Kvakova M, Kamlarova A, Stofilova J, Benetinova V, Bertkova I. Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy. World J Gastroenterol 2022; 28(27): 3370-3382. DOI: 10.3748/wjg.v28.i27.3370; 5-Year IF(2021): 5.742; SJR(2021): Q1;

Selected projects

OP VaI-VA-313011V336 Demand-driven research for the sustainable and innovative food, Drive4SIFood 313011V336, co-financed by the European Regional Development Fund OPVAI-VA/DP/2018/1.2.1-06 - participant

APVV-16-0176 Targeted modulation of gut microbiota and its transplantation in prevention and treatment of inflammatory bowel diseases- participant

VEGA-1/0393/20 Relationship between adherent and immunomodulatory properties of probiotic lactobacilli and the functionality and integrity of the intestinal barrier in inflammatory bowel diseases- participant

VVGS-2018-890 Support for better understanding of the human gut microbiome in order to develop novel microbiome modulation-based strategies for prevention and treatment of the cancerous diseases in central Europe- coordinator

International mobilities and visits
ProDigest, spin-off company from Ghent University, Technologiepark 4, B-9052 Ghent, Belgium, 25.04.-04.05.2019, Erasmus+

LF